Drugs Containing Excipient (Inactive Ingredient) ACETYLTRIBUTYL CITRATE

Branded drugs containing ACETYLTRIBUTYL CITRATE excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Padagis US LLC	ENTOCORT EC	budesonide	0574-9850	ACETYLTRIBUTYL CITRATE
3M Company	3M SOLUPREP	chlorhexidine gluconate and isopropyl alcohol	17518-080	ACETYLTRIBUTYL CITRATE	2026-01-20
Solventum US LLC	3M SOLUPREP S	chlorhexidine gluconate and isopropyl alcohol	17518-082	ACETYLTRIBUTYL CITRATE	2026-01-20
Physicians Total Care Inc	CARDIZEM CD	diltiazem hydrochloride	54868-2149	ACETYLTRIBUTYL CITRATE
Physicians Total Care Inc	ENTOCORT	budesonide	54868-4910	ACETYLTRIBUTYL CITRATE
Ferring Pharmaceuticals Inc	ORTIKOS	budesonide	55566-1002	ACETYLTRIBUTYL CITRATE

Generic drugs containing ACETYLTRIBUTYL CITRATE excipient

Company	Ingredient	NDC	Excipient
Amneal Pharmaceuticals of New York LLC	fenofibric acid	0115-1324	ACETYLTRIBUTYL CITRATE
Amneal Pharmaceuticals of New York LLC	dexmethylphenidate hydrochloride	0115-1686	ACETYLTRIBUTYL CITRATE
Amneal Pharmaceuticals of New York LLC	dexmethylphenidate hydrochloride	0115-1709	ACETYLTRIBUTYL CITRATE
Amneal Pharmaceuticals of New York LLC	dexmethylphenidate hydrochloride	0115-9922	ACETYLTRIBUTYL CITRATE
Walgreens Company	esomeprazole magnesium	0363-3298	ACETYLTRIBUTYL CITRATE
Walgreens	omeprazole	0363-9510	ACETYLTRIBUTYL CITRATE

Market Overview and Financial Outlook for Acetyltributyl Citrate

Last updated: February 7, 2026

Market Size and Demand Drivers

Acetyltributyl citrate (ATBC) is a citrate ester used primarily as a plasticizer, flavoring agent, and pharmaceutical excipient. Its primary application is in food packaging, pharmaceuticals, and personal care products. The global market for citrate esters, including ATBC, was valued at approximately $400 million in 2022, with an expected compound annual growth rate (CAGR) of 4.5% from 2023 to 2030 [1].

Key demand drivers include:

• Pharmaceutical Industry: Increasing use in oral and topical formulations. ATBC's non-toxic profile makes it suitable for drug delivery systems.
• Food Packaging: Rising trends in flexible and biodegradable packaging bolster demand.
• Personal Care: Growth in formulations requiring soft, flexible plastics.

Market Dynamics

• Supply Chain Factors: Raw material availability, notably citric acid and butanol, influences production capacity and cost. Fluctuations in crude oil prices impact the cost of butanol derivatives.
• Regulatory Environment: Stringent safety standards in food, pharma, and cosmetics sectors require comprehensive toxicity profiles, limiting market entry for unsubstantial products.
• Competitive Landscape: The market features a handful of key players, including Eastman Chemical Company, Sigma-Aldrich, and Jinxi Biological. These companies differentiate based on purity standards, application focus, and regional presence.
• Technological Advances: Innovations improving ATBC’s plasticizing efficiency and biodegradability extend its use, supporting market expansion.

Financial Trajectory

• Revenue Trends: Major producers report steady revenue growth, driven by expanding end-use applications. Eastman Chemical's Citrate esters division, including ATBC, recorded revenues of approximately $150 million in 2022, up 5% from 2021 [2].
• Pricing Patterns: Prices for ATBC have stabilized, with slight increases correlated to raw material costs. Average market price ranged from $8 to $12 per kilogram in 2022.
• Profitability: Gross margins for producers fluctuate within 20-30%, influenced by raw material costs and regulatory compliance expenses.
• Investment and R&D: Companies allocate funds toward developing bio-based and biodegradable variants, which could command premium pricing and open new markets.

Market Risks and Opportunities

Risks include raw material price volatility, regulatory hurdles, and competition from alternative plasticizers like phthalates or vegetable-based esters. Opportunities stem from increasing demand for non-toxic, biodegradable, and sustainable excipients, especially in developed markets.

Future Outlook

Projections for 2023-2030 indicate accelerated growth contingent on regulatory acceptance and innovation. Biosourced ATBC could expand faster, aligning with sustainability trends. The expansion in Asia-Pacific markets, driven by rising pharmaceutical and packaging industries, represents significant growth potential.

Key Financial Indicators Summary

Indicator	2022	2023 (Projected)	2030 (Forecast)
Market valuation	$400 million	$470 million	$700 million
CAGR	N/A	4.5%	4.5%
Producer revenues	~$150 million	$160 million	$250 million
Raw material price impact	Moderate increase	Stabilized	Slight increase

Conclusion

The growth trajectory of ATBC is steady, supported by its safe profile, expanding application scope, and environmental regulation trends favoring biodegradable plasticizers. Financial performance for established players remains resilient, with R&D focusing on sustainable variants presenting notable upside.

---

Key Takeaways

• The global ATBC market is projected to grow approximately 4.5% annually through 2030.
• Demand in pharmaceuticals, food packaging, and personal care remains the primary growth driver.
• Market participants benefit from stable pricing and increasing diversification into bio-based variants.
• Raw material cost fluctuations and regulatory hurdles pose ongoing risks.
• Asia-Pacific markets present significant expansion opportunities.

---

FAQs

1. What factors influence ATBC production costs?
Raw material prices, especially citric acid and butanol, directly impact costs. Oil price fluctuations affect butanol prices, while citric acid prices are influenced by fermentation industry trends.

2. How does regulatory compliance affect market growth?
Stringent safety standards require extensive testing and documentation, which can delay market entry for new products. However, approved and validated ATBC formulations gain broader acceptance.

3. What are the main competitors in the ATBC market?
Eastman Chemical, Sigma-Aldrich (a part of MilliporeSigma), and Jinxi Biological are leading suppliers. Competition focuses on product purity, regional presence, and bio-sourcing capabilities.

4. How likely is bio-based ATBC to displace traditional variants?
Increasing consumer demand and regulatory incentives for sustainable solutions support bio-based ATBC growth. Cost competitiveness remains a challenge but is improving with technological advances.

5. What regions offer the highest growth potential?
Asia-Pacific, driven by rapid pharmaceutical and packaging industry growth, offers the highest potential. North America and Europe focus on sustainable, bio-based formulations.

---

References

[1] MarketsandMarkets, “Citrate Esters Market by Type, Application, Region - Global Forecast to 2030,” 2022.

[2] Eastman Chemical Company Annual Report, 2022.